Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Non-Current Assets: 2023-2024

Historic Non-Current Assets for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $7.7 million.

  • Compass Therapeutics' Non-Current Assets rose 26.56% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 26.56%. This contributed to the annual value of $7.7 million for FY2024, which is 155.58% up from last year.
  • According to the latest figures from FY2024, Compass Therapeutics' Non-Current Assets is $7.7 million, which was up 155.58% from $3.0 million recorded in FY2023.
  • In the past 5 years, Compass Therapeutics' Non-Current Assets ranged from a high of $7.7 million in FY2024 and a low of $3.0 million during FY2023.
  • In the last 2 years, Compass Therapeutics' Non-Current Assets had a median value of $5.3 million in 2023 and averaged $5.3 million.
  • Data for Compass Therapeutics' Non-Current Assets shows a peak YoY skyrocketed of 155.58% (in 2024) over the last 5 years.
  • Over the past 2 years, Compass Therapeutics' Non-Current Assets (Yearly) stood at $3.0 million in 2023, then skyrocketed by 155.58% to $7.7 million in 2024.